Notify me when INHERENT GROUP, LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 8 | $108,136,882 | +$13,608,191 | -$25,453,585 | -$11,845,394 | COOP, NEE, OEC, IEMG, BLDR | 13F-HR | 14 Nov 2024, 14:44 |
| Q2 2024 | 13 | $113,740,122 | +$3,563,741 | -$67,236,228 | -$63,672,487 | COOP, OEC, NEE, IEMG, VITL | 13F-HR | 14 Aug 2024, 13:35 |
| Q1 2024 | 12 | $165,015,077 | +$19,585,100 | -$10,540,326 | +$9,044,774 | OEC, COOP, NEE, IEMG, VITL | 13F-HR | 15 May 2024, 13:27 |
| Q4 2023 | 10 | $154,466,506 | +$7,463,284 | -$32,394,756 | -$24,931,472 | OEC, COOP, IEMG, VITL, STEP | 13F-HR | 14 Feb 2024, 09:23 |
| Q3 2023 | 11 | $151,429,241 | +$4,792,327 | -$6,297,493 | -$1,505,166 | OEC, COOP, CAZOO GROUP LTD, IEMG, STEP | 13F-HR | 14 Nov 2023, 17:47 |
| Q2 2023 | 11 | $144,473,857 | +$111,405 | -$85,602,865 | -$85,491,460 | OEC, COOP, CAZOO GROUP LTD, IEMG, BRIDGEBIO PHARMA INC | 13F-HR | 14 Aug 2023, 15:47 |
| Q1 2023 | 19 | $239,624,414 | +$50,859,248 | -$83,859,344 | -$33,000,096 | OEC, COOP, CAZOO GROUP LTD, BRIDGEBIO PHARMA INC, FIS | 13F-HR | 15 May 2023, 16:11 |
| Q4 2022 | 17 | $234,630,105 | +$66,372,375 | -$80,705,449 | -$14,333,074 | VCSH, OEC, COOP, CAZOO GROUP LTD, BRIDGEBIO PHARMA INC | 13F-HR | 14 Feb 2023, 17:20 |
| Q3 2022 | 25 | $237,206,000 | +$84,406,175 | -$45,856,005 | +$38,550,170 | OEC, COOP, CAZOO GROUP LTD, VST, OAK STR HEALTH INC | 13F-HR | 14 Nov 2022, 10:19 |
| Q2 2022 | 23 | $196,564,000 | +$34,224,249 | -$112,782,567 | -$78,558,318 | OEC, OAK STR HEALTH INC, COOP, BRIDGEBIO PHARMA INC, XP | 13F-HR | 15 Aug 2022, 18:08 |
| Q1 2022 | 26 | $318,137,000 | +$119,590,731 | -$173,201,339 | -$53,610,608 | OEC, OAK STR HEALTH INC, COOP, UNVR, NEP | 13F-HR | 16 May 2022, 17:25 |
| Q4 2021 | 38 | $378,344,000 | +$113,074,421 | -$124,140,568 | -$11,066,147 | COOP, OEC, UNVR, ALLY, HUM | 13F-HR | 14 Feb 2022, 17:15 |
| Q3 2021 | 41 | $386,439,000 | +$90,972,073 | -$110,684,339 | -$19,712,266 | COOP, OEC, QS, MSFT, CANO | 13F-HR | 15 Nov 2021, 17:17 |
| Q2 2021 | 38 | $393,679,000 | +$150,497,945 | -$91,409,848 | +$59,088,097 | COOP, QS, STEP, POST, MSFT | 13F-HR | 16 Aug 2021, 17:27 |
| Q1 2021 | 35 | $325,575,000 | +$122,223,577 | -$50,515,441 | +$71,708,136 | COOP, POST, OEC, MSFT, LILAK | 13F-HR | 17 May 2021, 10:52 |
| Q4 2020 | 23 | $240,802,000 | +$104,081,433 | -$69,584,771 | +$34,496,662 | COOP, POST, MSFT, OEC, IEMG | 13F-HR | 16 Feb 2021, 17:26 |
| Q3 2020 | 21 | $200,767,000 | +$132,633,249 | -$16,678,909 | +$115,954,340 | VITL, LIBERTY LATIN AMERICA LTD, STEP, COOP, POST | 13F-HR | 16 Nov 2020, 17:07 |
| Q2 2020 | 16 | $75,995,000 | +$33,149,000 | -$63,949,915 | -$30,800,915 | EIX, NEE, OEC, MSFT, COOP | 13F-HR | 14 Aug 2020, 16:29 |
| Q1 2020 | 13 | $80,953,000 | +$40,149,994 | -$49,460,992 | -$9,310,998 | EIX, VCSH, OEC, LVGO, MSFT | 13F-HR | 15 May 2020, 09:37 |
| Q4 2019 | 7 | $116,253,000 | +$12,266,448 | -$20,441,635 | -$8,175,187 | EIX, OEC, INST, LVGO, DAR | 13F-HR | 14 Feb 2020, 16:30 |
| Q3 2019 | 7 | $107,563,000 | +$27,226,457 | $0 | +$27,226,457 | EIX, OEC, INST, TPIC, DAR | 13F-HR | 14 Nov 2019, 11:59 |
| Q2 2019 | 5 | $91,630,000 | +$22,186,497 | -$48,206,585 | -$26,020,088 | OEC, TPIC, INST, EIX, DAR | 13F-HR | 14 Aug 2019, 12:48 |
| Q1 2019 | 7 | $120,294,000 | +$22,874,801 | -$64,584,254 | -$41,709,453 | OEC, COOP, TPIC, DAR, INST | 13F-HR | 15 May 2019, 10:18 |
| Q4 2018 | 7 | $164,521,000 | $0 | $0 | $0 | CNC, COOP, OEC, ALLY, DAR | 13F-HR | 14 Feb 2019, 11:42 |